Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

"Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.

Gutierrez Najera NA, Resendis-Antonio O, Nicolini H.

Front Physiol. 2017 May 9;8:286. doi: 10.3389/fphys.2017.00286. eCollection 2017. Review.

2.

Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestry.

Hettige NC, Bani-Fatemi A, Kennedy JL, De Luca V.

BMC Psychiatry. 2017 Feb 9;17(1):63. doi: 10.1186/s12888-016-1180-3.

3.

Prevalence of Metabolic Syndrome in Patients with Schizophrenia in Korea: A Multicenter Nationwide Cross-Sectional Study.

Lee JS, Kwon JS, Kim D, Kim SW, Kim JJ, Kim JH, Nam HJ, Ryu S, Park IH, An SK, Oh HS, Won S, Lee K, Lee KY, Lee SH, Lee YS, Yi JS, Hong KS, Joo YH.

Psychiatry Investig. 2017 Jan;14(1):44-50. doi: 10.4306/pi.2017.14.1.44. Epub 2016 Dec 29.

4.

Study protocol: a cluster randomized controlled trial to assess the effectiveness of a therapeutic educational program in oral health for persons with schizophrenia.

Denis F, Millot I, Abello N, Carpentier M, Peteuil A, Soudry-Faure A.

Int J Ment Health Syst. 2016 Oct 5;10:65. eCollection 2016.

5.

Standardized Mortality Ratio in Patients with Schizophrenia - Findings from Thirthahalli: A Rural South Indian Community.

Bagewadi VI, Kumar CN, Thirthalli J, Rao GN, Suresha KK, Gangadhar BN.

Indian J Psychol Med. 2016 May-Jun;38(3):202-6. doi: 10.4103/0253-7176.183083.

6.

Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs.

van der Lee A, de Haan L, Beekman A.

PLoS One. 2016 Jun 8;11(6):e0157150. doi: 10.1371/journal.pone.0157150. eCollection 2016.

7.

Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder.

Vincenzi B, Greene CM, Ulloa M, Parnarouskis L, Jackson JW, Henderson DC.

J Psychiatr Pract. 2016 May;22(3):175-82. doi: 10.1097/PRA.0000000000000149.

8.

Excess Mortality in Patients with Severe Mental Disorders in 1996-2010 in Finland.

Lumme S, Pirkola S, Manderbacka K, Keskimäki I.

PLoS One. 2016 Mar 24;11(3):e0152223. doi: 10.1371/journal.pone.0152223. eCollection 2016.

9.

A Review of Impact of Tobacco Use on Patients with Co-occurring Psychiatric Disorders.

Pal A, Balhara YP.

Tob Use Insights. 2016 Mar 10;9:7-12. doi: 10.4137/TUI.S32201. eCollection 2016. Review.

10.

Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorder.

Beck AK, Baker A, Turner A, Haddock G, Kelly PJ, Berry K, Bucci S.

BMJ Open. 2015 Dec 23;5(12):e009985. doi: 10.1136/bmjopen-2015-009985. Review.

11.

Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia.

Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald AW 3rd, Ragland JD, Silverstein SM, Godwin D, Barch DM.

Schizophr Bull. 2016 May;42(3):753-61. doi: 10.1093/schbul/sbv148. Epub 2015 Oct 15.

12.

Validation of a Population-Based Algorithm to Detect Chronic Psychotic Illness.

Kurdyak P, Lin E, Green D, Vigod S.

Can J Psychiatry. 2015 Aug;60(8):362-8.

13.

Feasibility and acceptability of patient partnership to improve access to primary care for the physical health of patients with severe mental illnesses: an interactive guide.

Pelletier JF, Lesage A, Boisvert C, Denis F, Bonin JP, Kisely S.

Int J Equity Health. 2015 Sep 14;14:78. doi: 10.1186/s12939-015-0200-0.

14.

Relative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study.

Wu SI, Chen SC, Liu SI, Sun FJ, Juang JJ, Lee HC, Kao KL, Dewey ME, Prince M, Stewart R.

PLoS One. 2015 Aug 13;10(8):e0134763. doi: 10.1371/journal.pone.0134763. eCollection 2015.

15.

Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.

Kadra G, Stewart R, Shetty H, Jackson RG, Greenwood MA, Roberts A, Chang CK, MacCabe JH, Hayes RD.

BMC Psychiatry. 2015 Jul 22;15:166. doi: 10.1186/s12888-015-0557-z.

16.

Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.

Brunette MF, Dzebisashvili N, Xie H, Akerman S, Ferron JC, Bartels S.

Nicotine Tob Res. 2015 Aug;17(8):960-7. doi: 10.1093/ntr/ntv006.

17.

Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load.

Nugent KL, Chiappelli J, Rowland LM, Hong LE.

Psychoneuroendocrinology. 2015 Oct;60:120-9. doi: 10.1016/j.psyneuen.2015.06.009. Epub 2015 Jun 21.

18.

Serious mental illnesses associated with receipt of surgery in retrospective analysis of patients in the Veterans Health Administration.

Copeland LA, Zeber JE, Sako EY, Mortensen EM, Pugh MJ, Wang CP, Restrepo MI, Flynn J, MacCarthy AA, Lawrence VA.

BMC Surg. 2015 Jun 18;15:74. doi: 10.1186/s12893-015-0064-7.

19.

How Iranian women conceptualize mental health: an explanatory model.

Mirabzadeh A, Forouzan AS, Mohammadi F, Dejman M, Baradaran Eftekhari M.

Iran J Public Health. 2014 Mar;43(3):342-8.

20.

E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.

O'Brien B, Knight-West O, Walker N, Parag V, Bullen C.

Tob Induc Dis. 2015 Mar 24;13(1):5. doi: 10.1186/s12971-015-0030-2. eCollection 2015.

Supplemental Content

Support Center